M3 (2413) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
6 Aug, 2026Executive summary
Q1 FY2026 revenue rose 5% year-over-year to JPY 90,105 million, with most segments performing in line with expectations except for Overseas, which lagged.
Operating profit declined 9% year-over-year to JPY 18,077 million, and profit before tax fell 5% to JPY 18,641 million.
Net profit dropped 22% year-over-year to JPY 10,579 million, impacted by a one-time tax provision related to overseas dividends.
Profit attributable to owners of the parent dropped 23.4% year-over-year to 9,074 million yen.
Comprehensive income rose 13.5% year-over-year to 14,075 million yen.
Financial highlights
Revenue: JPY 90,105 million (+5% YoY); Operating profit: JPY 18,077 million (-9% YoY); Net profit: JPY 10,579 million (-22% YoY, adjusted for one-time tax provision).
Most segments met initial forecasts, but overall results were slightly below plan due to Overseas segment underperformance.
Operating profit margin decreased as operating profit fell despite revenue growth.
Basic earnings per share for the quarter were 13.60 yen, down from 17.44 yen year-over-year.
Total assets as of June 30, 2026, were 634,803 million yen, with equity ratio stable at 64.0%.
Outlook and guidance
Management maintains a medium- to long-term growth outlook, focusing on expanding business foundation and leveraging AI and M&A for sustainable growth.
AI is expected to drive further operational efficiency and value creation, with over 100 AI-related projects underway.
Full-year revenue forecast for fiscal year ending March 31, 2027, is 400,000 million yen, up 13.8% year-over-year.
Operating profit is projected to reach 80,000 million yen, up 8.8% year-over-year.
Profit attributable to owners of the parent is forecast at 53,000 million yen, up 7.9% year-over-year.
Latest events from M3
- Record profit and double-digit growth achieved, with AI and global expansion driving future gains.2413
Q4 2026 - AI-driven growth, record financials, and expanding ecosystem define FY2025 performance.2413
Investor presentation - Strong revenue and profit growth led by segment expansion, digital, and overseas businesses.2413
Q3 2026 - H1 FY2025 revenue rose 37% and profit 24%, led by core segments and new business consolidation.2413
Q2 2026 - Revenue and profit jumped in Q1, fueled by segment growth and recent acquisitions.2413
Q1 2026 - Revenue up 8% YoY, profit down 16%, with M&A and digital growth as key drivers.2413
Q2 2025 - Revenue up 12% but profit down 6% as core segments grow and COVID-related sales decline.2413
Q1 2025 - Revenue up 19% YoY; FY2025 outlook strong with 26% growth forecast and new segment.2413
Q4 2025 - Revenue up 15% YoY, profit down, new Patient Solution segment from ELAN acquisition.2413
Q3 2025